KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to $416.5 million.

  • Exact Sciences' Accumulated Expenses rose 2686.05% to $416.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $416.5 million, marking a year-over-year increase of 2686.05%. This contributed to the annual value of $416.5 million for FY2025, which is 2686.05% up from last year.
  • Per Exact Sciences' latest filing, its Accumulated Expenses stood at $416.5 million for Q4 2025, which was up 2686.05% from $408.8 million recorded in Q3 2025.
  • In the past 5 years, Exact Sciences' Accumulated Expenses registered a high of $416.5 million during Q4 2025, and its lowest value of $214.1 million during Q1 2021.
  • In the last 5 years, Exact Sciences' Accumulated Expenses had a median value of $308.1 million in 2022 and averaged $315.3 million.
  • As far as peak fluctuations go, Exact Sciences' Accumulated Expenses surged by 9067.2% in 2021, and later crashed by 3390.72% in 2023.
  • Quarter analysis of 5 years shows Exact Sciences' Accumulated Expenses stood at $398.6 million in 2021, then decreased by 24.92% to $299.2 million in 2022, then increased by 14.19% to $341.7 million in 2023, then fell by 3.92% to $328.3 million in 2024, then grew by 26.86% to $416.5 million in 2025.
  • Its last three reported values are $416.5 million in Q4 2025, $408.8 million for Q3 2025, and $317.2 million during Q2 2025.